Newsroom

Press Releases, Media Coverage and Publications

Press Releases

Capsida Biotherapeutics Enters Strategic Collaboration With Kate Therapeutics to Manufacture KateTx’s Next-Generation Gene Therapies

October 3, 2023

Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases

June 8, 2023

Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430

June 8, 2023

Media Coverage

Highlights from Kate Therapeutics’ Panel at the WuXi Global Forum

January 30, 2024

New Drugs May Help Rebuild Momentum against Cardiovascular Disease [GEN]

October 10, 2023

The 20 Under 40 in Biopharma [Endpoint News]

April 19, 2022

A Boost for Muscle with Gene Therapy [NEJM]

March 24, 2022

Determined Yet Patient, He Looks for a Cure [New York Times]

November 4, 2021

Engineering a Better Way to Deliver Therapeutic Genes to Muscles [NIH Director’s Blog]

September 21, 2021

Featured Publications

Directed Evolution of a Family of AAV Capsid Variants Enabling Potent Muscle-directed Gene Delivery Across Species

Media Contact

Kathy Vincent
Greig Communications, Inc.
kathy@greigcommunications.com

Subscribe to Receive News Alerts

Fill out my online form.